Research ArticleClinical Investigation
68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
Journal of Nuclear Medicine December 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897
Farshad Moradi
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California;
Heying Duan
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California;
Hong Song
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California;
Guido A. Davidzon
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California;
Benjamin I. Chung
2Department of Urology, Stanford University, Stanford, California; and
Alan E. C. Thong
2Department of Urology, Stanford University, Stanford, California; and
Andreas M. Loening
3Division of Body MRI, Department of Radiology, Stanford University, Stanford, California
Pejman Ghanouni
3Division of Body MRI, Department of Radiology, Stanford University, Stanford, California
Geoffrey Sonn
2Department of Urology, Stanford University, Stanford, California; and
Andrei Iagaru
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California;

SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn, Andrei Iagaru
Journal of Nuclear Medicine Dec 2022, 63 (12) 1822-1828; DOI: 10.2967/jnumed.122.263897
68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn, Andrei Iagaru
Journal of Nuclear Medicine Dec 2022, 63 (12) 1822-1828; DOI: 10.2967/jnumed.122.263897
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.